Diabetes mellitus with pathological variants in the GATA6 gene, as in our case, usually requires low doses of insulin (0.2–0.35 U/kg/day), which correlates with the β-cell mass [18], and treatment with sulfonylurea in GATA6 syndrome is unsuccessful [15]. This evidence concerns the gene INS and Down syndrome.